Multi-Variate Testing Is The Key To Customer Personalization And Satisfaction

Ecommerce personalization is expected by 83 percent of all consumers. This strategy is dependent on artificial intelligence or AI, and significantly boosts consumer sales. Multi-variate testing allows businesses to use algorithms to define the preferences, past and future purchasing requirements, and overall behavior of consumers. The process is automated, efficient, fast and the insights provided are high quality.

AI provides consumers with recommended products based on their personal preferences. This technology can be accessed from the smallest business to the massive companies. This strategy is incredibly effective because consumers are being presented with products that appeal to their individual preferences. The future behavior of the consumers can be accurately predicted using a few key metrics.

Multi-variate testing can accomplish in a few months what would take a team of employee’s years. Businesses are using real time data to turn consumer visits into sales. Instead of individually tracking the various factors including a call to action, website navigation, or consumer preferences, all these factors are tracked simultaneously with AI. The different tests are effectively analyzed, an enormous quantity of ideas are considered, and time is saved because the wrong metrics are no longer pursued.

Businesses are using multi-variate testing to determine which customers are most likely to remain, and which will leave. The technology cleans up the company’s datasets including account length, usage, location and churn. The initial parameters still require some tweaking to eliminate any errors in predictions, but the process is being perfected. This allows marketers to use a proactive approach, so their opportunities are precisely targeted. The multi-variate testing algorithms allow the brand to gain confidence from the consumers. This process will eventually retain customer loyalty with nothing more required than a small discount.

The key to sales is customer satisfaction. This is accomplished by monitoring customer data. This creates transparence, which can be used to help control website clicks, mobile device usage, social posts, and shopping cart behavior. AI can even be used to interpret social media networks. Algorithms reveal the way brands are referenced using real time. This allows for more positive promotions with less complaints. Business decisions can be based on negative or positive responses.

Customer service must be personalized to the greatest possible degree. The amount of data available must be used to effectively ensure every buying experience is unique and satisfactory for the consumer. This requires the use of AI technology to stay ahead of the competition, and keep customers coming back.

Congratulations to Madison Street Capital for Their Top Achievements

As an international banking firm that specializes in global investments, Madison Street Capital is considered a leader in providing corporate financial services in mergers, acquisitions, business valuation services and other financial options. Madison Street Capital has global wealthy clients that look to this firm to grow their market portfolios and investment assets. Due to their reputation, Madison Street Capital was nominated for the 16th Annual M & A Advisor Award.

The awards gala was held on Monday, November 13th at the 2017 at the New York Metropolitan Club. The category that the banking firm was named is as a finalist for the Boutique Investment Banking Firm of the Year. Madison, at the same time, was also nominated in two other categories identified as the Financials Deal of the Year and the Debt Financing of the Year award.

Respectfully, both awards recognized Madison as acquiring financially succesful deals and for the debt financing award, Madison was recognized as an outstanding advisor in the WLR Automotive transaction. The Annual M & A Advisor Award program was created in 1998. The M & A Advisor Awards recognize leaders in various financial industries that have introduced innovative products and integrated services. The Annual M & A Gala is the financial industry’s top celebration of the year for over 500 industry M & A Dealmakers and M & A professionals and which is also held in conjunction with the M & A Advisor Summit.

In the acknowledgement of these awards, Charles Botchway, the Chief Executive Officer and Founder of Madison Street Capital stated that their goal is to provide quality service to the middle marketplace that is often underserved and to be recognized for it makes their efforts a wonderful event. For the WLR Automotive award Mr. Botchway thanked Barry Petersen, the Senior Managing Director of Madison Street Capital for leading this transaction.

The 16th Annual M & A Advisor Award consists of ten top sectors and many subset categories were global firms which are recognized for their varied deals of the year, product/service of the year, acquisitions of the year, etc (https://www.youtube.com/watch?v=jmbzaVSuCmU). The M & A judges acknowledge the highest levels of achievement for companies representing middle market to multi-billion-dollar deals by the M & A Awards which took place on November 13, 2017 at the Metropolitan Club. Madison Award Capital won the Debt Financing of the Year Award for their role in the WLR Automotive transaction.

Reasons why Securus Technologies is the Leading Supplier of Technology in Correctional Facilities.

Securus Technologies is a private company that is well-known in the corrections sector and telecommunication industry. The company was primarily established to provide technological solutions and security services in prisons across the United States and Canada. Rick Smith currently heads the firm since his appointment in 2008 as the chief executive officer. The quality of services offered by Securus Technologies attracted over two thousand law enforcement facilities that hold over one million inmates across North America. The firm uses most of its resources in investing in technology that helps to reduce crime by increasing safety of individuals, parole constables, and detainees. The company prides itself on having over one thousand skilled professional employees.

 

Since its inception, Securus Technologies continues to serve locals and correction facilities situated in Carrolton, Allen, Georgia, and Atlanta. The company is singled out in the United States as a leading communication provider for inmates. The firm offers product monitoring services through software, which helps several industries in identifying contraband commodities. The LBS software that was designed by the corporation helps parole officers on investigation matters. Inmates across North America communicate with their loved ones through calls offered by Securus Technologies. Technological solutions provided by the company help parole officers monitor inmate activities, which reduces cases of substance use in correctional facilities. The firm ensures that programs are updated weekly to ensure that security is beefed up in law enforcement institutions.

 

Several organizations and individuals who contracted Securus Technologies praise the company through letters and emails. The incredible reputation earned by the company saw it awarded a five-star rating from the Better Business Bureau. The firm meets and exceeds the needs of its clients who seek technological solutions related to security. Transactions within the company have been automated through an online platform established after acquiring JPay Incorporation. Securus Technologies is currently the top supplier of Offender Management Systems across the universe.

 

Cancer Treatment Centers Of America Improves Patient’s Care Through Collaboration

Cancer Treatment Centers of America (CTCA)has once again thought outside the box in relation to cancer care. A new collaboration was announced between Allscripts, NantHealth, and the Cancer Treatment Centers of America that would cut down on the guesswork in choosing the proper treatment pathway for a patient’s cancer diagnoses. The Clinical Pathways program is composed of Allscripts’ Sunrise, electric health record, and NantHealth’s “eviti“, a comprehensive support program, listing all data complied regarding any type of cancer and cross referencing this information with all possible treatment plans.

This program allows a more efficient exchange of information, while not interfering with the doctor’s work flow. Eviti also allows the patient greater access of information surrounding the type and stage of their cancer diagnosis, help them choose the best plan of care for their situation. The Eviti portion of Clinical Pathways has been developed compiling the most comprehensive and up to date treatments, medical research, and pharmaceutical information available. Eviti is kept updated by a team of oncologists, oncology nurses, a board of certified oncology experts, and technical experts.

This collaboration is the latest step in offering the best in cancer care at Cancer Treatment Centers of America. Headquartered in Boca Raton, Florida with buildings in Philadelphia, Atlanta, Chicago, Phoenix, and Tulsa, Cancer Treatment Centers of Americahas been consistently ranked as one of the top hospitals for a high standard of patient care several years running.

CTCA believes in treating the patient as a whole (mind, body, and soul) offering treatments to support the patient while they are going through cancer treatment. Cancer Treatment Centers of America even offers aftercare therapy for when a patient has finished their course of treatments. CTCA specializes in: precision cancer treatment, surgery, radiation, chemotherapy, immunotherapy, and genomic testing. To read more about the partnership, please click here.

Mikhail Blagoskloony’s Groundbreaking Research on Cancer

Mikhail Blagosklonny is popularly known for his groundbreaking research for finding cures for cancer patient alongside therapies for advanced stages of the same. He works at Rosewell Park Cancer Institute, New York at the Department of Oncology. As a professor, he has created awareness about Rapamycin and enlightened his students and other people about the curative and anti-aging properties of the drug. Commonly known as Rapamune in the drug market, Rapamycin has proved to be an effective drug administered to patients who have undergone organ transplant to prevent the body system from rejecting the new transplanted organ or tissue.This drug surfaced in 1972 when scientists discovered its immunosuppressive properties and its ability to cure certain types of cancer. Patients suffering from hemolytic uremic syndrome also have the advantage of evading the complications that result from kidney failures and low levels of blood in their body. This is because Rapamycin helps in curbing these effects. Other diseases that the drug cures include lymphangioleiomyomatosis which is a lung condition prevalent in a few percentages of pregnant women.

As an oncologist, Dr. Mikhail has advice his fellow doctors to use more of Rapamycin in cancer patients who undergo the procedures of organ transplant. Not only does it enhances tumor regression but has also proven to cure specific types of cancer that these patients have been diagnosed with. However, Dr. Mikhail is still conducting studies and research about the anti-aging properties of the drug, the curative properties of the drug when it comes to patients with Alzheimer’s and much more. In addition, scientists are in their quest to find drugs for Muscular Dystrophy and immunosuppression of systemic lupus erythematosus using Rapamycin. Dr. Mikhail being at the forefront of the scientific research is positive that this drug will help in treating many diseases considering their research findings on Rapamycin.Dr. Mikhail Blagosklonny believes that the world has the best drug at their disposal and hopes that the number of cancer patients will reduce effectively with time. His medical research on the drug, Rapamycin has rescued many who are not able to afford expensive treatment because he offers treatment on very affordable terms. His major interest has been on the anti-aging properties of the drug as well as its ability to cure cancer.

The students that he lectures have had one of the best professors of their lifetime. His mode of teaching is more of an inspiration rather than the normal serious class setting. These students are anticipating finishing their studies and continuing the research that their renowned professor established.Most of all, Dr. Mikhail Blagosklonny’s lifelong desire is to advance his cancer research and find an easier way of treating cancer without having to damage another body cell considering how first cancer spreads alongside the therapies that may overlap into the healthy tissues.The contributions that this passionate oncologist has put into cancer research have helped in upgrading the treatment that existed before and even advancing the equipment used for cancer therapies. Indeed, the number of cancer patients has reduced gracefully with increased awareness about the tragic disease. Thanks to Dr. Mikhail Blagosklonny’s.